Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications. | Front Immunol | 2022 | 35669776 | PubTator, text mining | PubMed |
| The Role of Schwann Cells in Cancer. | Adv Biol (Weinh) | 2022 | 35666078 | PubTator, text mining | PubMed |
| Adhesion molecules in multiple myeloma oncogenesis and targeted therapy. | Int J Hematol Oncol | 2022 | 35663420 | PubTator, text mining | PubMed |
| How genetic risk contributes to autoimmune liver disease. | Semin Immunopathol | 2022 | 35650446 | PubTator, text mining | PubMed |
| Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence. | Leukemia | 2022 | 35643867 | PubTator, text mining | PubMed |
| Differential Expression of Super-Enhancer-Associated Long Non-coding RNAs in Uterine Leiomyomas. | Reprod Sci | 2022 | 35641855 | PubTator, text mining | PubMed |
| Targeting protein-protein interaction for immunomodulation: A sunflower trypsin inhibitor analog peptidomimetic suppresses RA progression in CIA model. | J Pharmacol Sci | 2022 | 35641025 | PubTator, text mining | PubMed |
| A rare case of B-lymphoid blast phase of chronic myeloid leukemia: Diagnostic challenges. | Leuk Res Rep | 2022 | 35634195 | PubTator, text mining | PubMed |
| Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia: Egyptian Experience. | Asian Pac J Cancer Prev | 2022 | 35633549 | PubTator, text mining | PubMed |
| Molecular Diagnostic Review of Diffuse Large B-Cell Lymphoma and Its Tumor Microenvironment. | Diagnostics (Basel) | 2022 | 35626243 | PubTator, text mining | PubMed |
| Genetic Alterations in Adult T-Cell Leukemia/Lymphoma: Novel Discoveries with Clinical and Biological Significance. | Cancers (Basel) | 2022 | 35625999 | PubTator, text mining | PubMed |
| An NF-κB- and Therapy-Related Regulatory Network in Glioma: A Potential Mechanism of Action for Natural Antiglioma Agents. | Biomedicines | 2022 | 35625673 | PubTator, text mining | PubMed |
| CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma. | Virchows Arch | 2022 | 35622145 | PubTator, text mining | PubMed |
| The CD58-CD2 axis in cancer immune evasion. | Nat Rev Immunol | 2022 | 35589965 | PubTator, text mining | PubMed |
| Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature. | Front Immunol | 2022 | 35572607 | PubTator, text mining | PubMed |
| Dynamic Interplay between Structural Variations and 3D Genome Organization in Pancreatic Cancer. | Adv Sci (Weinh) | 2022 | 35570408 | PubTator, text mining | PubMed |
| The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value. | J Clin Med | 2022 | 35566637 | PubTator, text mining | PubMed |
| Congenital Aneuploidy in Klinefelter Syndrome with B-Cell Acute Lymphoblastic Leukemia Might Be Associated with Chromosomal Instability and Reduced Telomere Length. | Cancers (Basel) | 2022 | 35565445 | PubTator, text mining | PubMed |
| Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomes. | Mol Med | 2022 | 35562651 | PubTator, text mining | PubMed |
| Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis. | EBioMedicine | 2022 | 35561450 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=30